15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Several molecular technologies aimed at regulating gene expression that have been recently developed as a strategy to combat inflammatory and neoplastic diseases. Among these, antisense technology is a specific, rapid, and potentially high-throughput approach for inhibiting gene expression through recognition of cellular RNAs. Advances in the understanding of the molecular mechanisms that drive tissue damage in different inflammatory diseases, including Crohn’s disease (CD) and ulcerative colitis (UC), the two major inflammatory bowel diseases (IBDs) in humans, have facilitated the identification of novel druggable targets and offered interesting therapeutic perspectives for the treatment of patients. This short review provides a comprehensive understanding of the basic concepts underlying the mechanism of action of the oligonucleotide therapeutics, and summarizes the available pre-clinical and clinical data for oligonucleotide-based therapy in IBD.

          Related collections

          Most cited references58

          • Record: found
          • Abstract: not found
          • Article: not found

          Inflammatory bowel disease.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Phosphorothioates, essential components of therapeutic oligonucleotides.

            Phosphorothioates have found their usefulness in the general area of oligonucleotide therapeutic applications. Initially this modification was introduced into the antisense methodology because of the nuclease resistance of the phosphorothioate linkage in comparison with that of the phosphate linkage. However, as experimental data accumulated, it was detected that this chemical modification also facilitates cellular uptake and bioavailibity in vivo. Thus, today the majority of therapeutic oligonucleotides contain this modification. This review will discuss the historical development of this modification and present some of its chemical properties where they differ from those of the phosphate group. The antisense application will be discussed in the original context with cleavage of the target mRNA, but other target RNAs such as microRNAs and long noncoding RNAs will also be covered. It continues with applications where the target RNA should not be cleaved. A brief presentation of decoy oligonucleotides will be included, as well as some miscellaneous applications. Cellular uptake is a crucial step for oligonucleotides to reach their target and will be briefly reviewed. Lastly, a most surprising recent observation is the presence of phosphorothioate groups in bacterial DNA where functions still remain to be fully determined.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Sfold web server for statistical folding and rational design of nucleic acids.

              The Sfold web server provides user-friendly access to Sfold, a recently developed nucleic acid folding software package, via the World Wide Web (WWW). The software is based on a new statistical sampling paradigm for the prediction of RNA secondary structure. One of the main objectives of this software is to offer computational tools for the rational design of RNA-targeting nucleic acids, which include small interfering RNAs (siRNAs), antisense oligonucleotides and trans-cleaving ribozymes for gene knock-down studies. The methodology for siRNA design is based on a combination of RNA target accessibility prediction, siRNA duplex thermodynamic properties and empirical design rules. Our approach to target accessibility evaluation is an original extension of the underlying RNA folding algorithm to account for the likely existence of a population of structures for the target mRNA. In addition to the application modules Sirna, Soligo and Sribo for siRNAs, antisense oligos and ribozymes, respectively, the module Srna offers comprehensive features for statistical representation of sampled structures. Detailed output in both graphical and text formats is available for all modules. The Sfold server is available at http://sfold.wadsworth.org and http://www.bioinfo.rpi.edu/applications/sfold.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Pharmacol
                Front Pharmacol
                Front. Pharmacol.
                Frontiers in Pharmacology
                Frontiers Media S.A.
                1663-9812
                29 March 2019
                2019
                : 10
                : 305
                Affiliations
                [1] 1 Department of Systems Medicine, Gastroenterology, University of Tor Vergata , Rome, Italy
                [2] 2 Department of Pharmacy, School of Medicine and Surgery, University of Naples “Federico II” , Naples, Italy
                Author notes

                Edited by: Ruixin Zhu, Tongji University, China

                Reviewed by: Zhanju Liu, Tongji University, China; Jose A. Uranga, Universidad Rey Juan Carlos, Spain; Anthony C. Johnson, Oklahoma City VA Health Care System, United States; Oksana Zayachkivska, Danylo Halytsky Lviv National Medical University, Ukraine

                *Correspondence: Davide Di Fusco, davidedifusco@ 123456gmail.com

                These authors have contributed equally to this work

                This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology

                Article
                10.3389/fphar.2019.00305
                6450224
                30983999
                4319bfe0-ddd2-4004-8c3f-6a64084c8e9a
                Copyright © 2019 Di Fusco, Dinallo, Marafini, Figliuzzi, Romano and Monteleone.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 03 December 2018
                : 12 March 2019
                Page count
                Figures: 1, Tables: 0, Equations: 0, References: 69, Pages: 7, Words: 5661
                Categories
                Pharmacology
                Mini Review

                Pharmacology & Pharmaceutical medicine
                inflammatory bowel disease,ulcerative colitis,crohn’s disease,antisense oligonucleotide,rna interference

                Comments

                Comment on this article